HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. (Q38223328)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2014

Language	Label	Description	Also known as
English	HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.	scientific article published on September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

0 references

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Phillip Chan

1

1 reference

Europe PubMed Central

31 August 2017

Bruce J Brew

2

1 reference

Europe PubMed Central

31 August 2017

publication date

1 September 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Current HIV/AIDS reports

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

317-324

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

https://scigraph.springernature.com/pub.10.1007/s11904-014-0221-0

0 references

Neurological complications of HIV infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

The prevalence and incidence of neurocognitive impairment in the HAART era.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Neuropsychologic impairment in early HIV infection. A risk factor for work disability.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Paradoxes of adherence and drug resistance to HIV antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Mild cognitive impairment and risk of mortality in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Parkinsonism in hiv-infected patients on highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Disruption of neuronal autophagy by infected microglia results in neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Altered proteasomal function in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Persistent hijacking of brain proteasomes in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Diffusion Tensor Imaging of the Brain

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Frontostriatal fiber bundle compromise in HIV infection without dementia

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

The effects of HIV and combination antiretroviral therapy on white matter integrity

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Greater than age-related changes in brain diffusion of HIV patients after 1 year

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

HIV-associated neurocognitive disorders: antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Molecular and pathologic insights from latent HIV-1 infection in the human brain

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Lost in translation: again, another failed neuroprotection trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion alterations in corpus callosum of patients with HIV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The HIV Dementia Scale: predictive power in mild dementia and HAART

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV Dementia Scale: a rapid screening test.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

gp120-induced alterations of human astrocyte function: Na(+)/H(+) exchange, K(+) conductance, and glutamate flux

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV protease inhibitor exposure predicts cerebral small vessel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11904-014-0221-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38223328&oldid=1510296496"